Fig. 1From: Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patientsBaseline levels of FPG in T2DM patients with different MTNR1B rs10830963 genotypes. Data are expressed as (mean ± SD). *P < 0.05 compared with CC genotype groupBack to article page